(Q71455446)
Statements
A multicentre phase II study of the efficacy and safety of docetaxel as first-line treatment of advanced breast cancer: report of the Clinical Screening Group of the EORTC (English)
P Fumoleau
B Chevallier
P Kerbrat
Y Krakowski
J L Misset
C Maugard-Louboutin
V Dieras
N Azli
N Bougon
A Riva
1 February 1996